Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

157.52 -7.41 (-4.49%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Peering Into Zoetis's Recent Short Interest
Via Benzinga
The June Watch List
Keep the rules simple, and then consider using puts and credit spreads to your advantage. 
Via Talk Markets
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
Beat the Dow Jones With This Cash-Gushing Dividend Stock
With one decade of doubling the Dow Jones' total return under its belt, Zoetis looks ready to deliver another 10 years of outperformance. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Zoetis Declares Third Quarter 2024 Dividend
From Zoetis Inc.
Via Business Wire
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
Zoetis Earnings Top; Pet Drugmaker Rises
First-quarter earnings and sales slightly topped first-quarter estimates. 
Via Investor's Business Daily
Zoetis to Participate in the William Blair 44th Annual Growth Stock Conference
From Zoetis Inc.
Via Business Wire
Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference
From Zoetis Inc.
Via Business Wire
Zoetis Named a Top Company for DE&I by Fair360 (Formerly DiversityInc.)
From Zoetis Inc.
Via Business Wire
Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
Invest smarter with Wall Street's exchange-traded funds and seize market momentum with these thematic ETFs to buy. 
Via InvestorPlace
Topics ETFs
4 Oversold Stocks to Buy Right Now
Here are four stocks to buy now that could offer investors upside in the short and long term. 
Via The Motley Fool
Elanco Makes A Bullish Move On Its First Quarter Beat; Are Pet Health Stocks Forging A Comeback?
Elanco is the second animal health company to report better-than-expected first-quarter metrics. 
Via Investor's Business Daily
Bragar Eagel & Squire, P.C. Is Investigating Zoetis, and Morgan Stanley and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
WHY: NEW YORK, NY - (NewMediaWire) - May 05, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zoetis Inc.... 
Via TheNewswire.com
Exposures Product Safety
ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
From The Rosen Law Firm PA
Via GlobeNewswire
Zoetis (ZTS) Q1 2024 Earnings Call Transcript
ZTS earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Zoetis Stock Popped by Almost 6% on Thursday
An estimates-beating quarter and raised guidance made the company a pet stock for many investors. 
Via The Motley Fool
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?
U.S. stock markets surged during Thursday’s midday trading session in New York, with major averages all showing gains. 
Via Benzinga
Topics Economy
Exposures Interest Rates
ZTS Stock Earnings: Zoetis Beats EPS, Beats Revenue for Q1 2024
ZTS stock results show that Zoetis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Why Animal Health-Focused Zoetis Shares Are Trading Higher Today
Zoetis Inc (NYSE: ZTS) beats revenue expectations with 10% Y/Y increase. U.S. segment up 16%, international up 3%. FY24 guidance revised higher. ZTS shares up 4.66%. 
Via Benzinga
Zoetis Announces First Quarter 2024 Results
From Zoetis Inc.
Via Business Wire
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
Despite the post-pandemic slowdown, the pet care industry remains healthy, as these three AI pet stocks to buy now demonstrate. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
ZTS LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
ZTS LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
WHY: NEW YORK, NY - (NewMediaWire) - May 1, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zoetis Inc.... 
Via TheNewswire.com
Exposures Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.